Product Catalog

www.xiamenbiotime.com
COMPANY PROFILE

Established in April, 2008, Xiamen Biotime is a hi-tech enterprise that

specializes in R&D, production and sales of POCT in vitro diagnostic
devices and reagents. Biotime has always been carrying the faith of
"Quality Comes From Professionalism And Service Makes The Future".
Committed to“Being Unique From Our Competitors", we have success-
fully established our mature medical marketing channels during the
past years. With our leading technologies, Biotime aims to develop
superior IVD products which provide better solutions for health care and
benefit people all over the world.

200,000+ 80+
Square Meters of Manufacturing Countries

800+ 5+
Global Distributors R&D Centers

2000+ 200+
Dedicated Employees Researchers
CONTENT
Fluorescence Immunoassay Analyzer
BIOT-YG-I 01
FLI-100 02
FLI-600 03
ICE-100E 04

Fluorescence Immunoassay Rapid Quantitative Test

Cardiac Marker LH 07
cTnI 05 PRL 07
Myo 05 FSH/LH/PRL(3 in 1) 07
CK-MB 05 TES(Testosterone) 07
cTnI/Myo/CK-MB (3 in 1) 05 E2 07
D-Dimer 05 AMH 07
NT-proBNP 05
cTnI/Myo/CK-MB/D-Dimer /NT-proBNP (5 in 1) 05 Diabetes and Renal Injury Marker

hFABP 05 HbA1c 08
BNP 05 MAU 08
LP-PLA2 05 Cys-C 08
HCY 05
s100-β 05 Thyroid marker
hscTnI 05 TSH 08
TT4 08
Tumor Marker
TT3 08
AFP 06
CEA 06
Gastrointestinal marker
CEA/AFP(2 in 1) 06 2 in 1（PG I/PG II) 09
tPSA 06 PG I/PG II/G17 09
fPSA 06

Others
Inflammatory Marker Ferritin 09
CRP 06 25（OH）-D 09
PCT 06 Total IgE 09
SAA 06
CRP/SAA(2 in 1) 06
IL-6 06

Hormone Marker

β-HCG 07
PROG 07
FSH 07
0

IMMUNOFLUORESCENCE
PLATFORM

Immunoassay is a highly selective bio-analytical method. It is based on the specificity

of antibodies to their antigen. The advantages of this method include higher sensitivity
detection of the analytes, simplified reagents, and simpler assay designs.
Fluorescence Immunoassay Analyzer

BIOT-YG-I FIA Analyzer

Instant Result
Convenient and fast
Get results in 3-20 minutes
Compatibility
Applied for all BIOTIME FIA parameters

Trend Tracking Accurate and Rapid

Used for disease monitoring CV≤3%
Linear correlation coefficient≥0.99

Power Bank
Room Temperature Storage
Optional choice for power failure
or ambulance Can be stored at room temperature (2-30℃)

Product Specification

Specimen Whole Blood/Serum/Plasma/Urine

Connection LIS/HIS, RS232, USB, Ethernet

User Interface Touch screen

Time to Result 3-20 mins

CV ≤3%

Result Storage 5,000

Power Input AC220V, 3A, 50/60Hz

Dimension 280（L）x256（W）x102（H）mm

Weight 2.9kg

Test Procedure

ge
Cartrid

HbA1c SD Card

ID:
SD Card

Loading Inserting Testing Reading

PAGE/01
 FLI-100 FIA Analyzer

Advanced Stability
2 hours testing
User Friendly 24 hours standby time on battery

7 inch touchscreen

Smart System Improved Mobility

Multilingual operational system Built-in removable batteries

Intelligent Workload
Patient history tracking Easy-to-use Design
Automatic self-check system

Product Specification

Specimen Whole Blood/Serum/Plasma/Urine

Connection LIS/HIS, USB 2.0 X 2, RS232 X2, Ethernet on RJ45 X 1

User Interface Integrated 7 inch touch screen

Time to Result 3-20 mins

CV ≤3%

Result Storage 10000+

Power Input DC12V, 5.0A

Dimension 240（L）x200（W）x150（H）mm

Weight 2.78kg

Test Procedure

Cartridge

HbA1c

ID:

Loading Inserting Testing Reading

PAGE/02
FLI-600 FIA Analyzer

Decision Making
Multi Channels With trend tracking history

6 channels to test simultaneously

Robust Zero Pollution

Sharp constant temperature system With discard holder provided

Easy to Operate Intelligent Workload

10.1 inch touch screen with windows Built-in multiple modules selectivity
10 operation system

Product Specification

Specimen Whole Blood/Serum/Plasma/Urine

Connection LIS/HIS, RS232, USB, Ethernet

User Interface 10.1 inch touch screen

Time to Result 3-20 mins

CV ≤3%

Result Storage 300, 000

Power Input AC220V, 3A, 50/60Hz

Dimension 410（L）x398（W）x282（H）mm

Weight 14kg

Test Procedure

SD Card

Prepare for test Insert SD card Place cartridge Sampling & Mixing Loading Testing
into the slot

PAGE/03
 ICE-100E Incubation Chamber

Multiple Slot Capacity

6 Incubation card slots
Ideal Operating Temperature-Set Get result in 3 to 30 minutes
20~40°C

Dimension and Weight

220*160*72mm 1.4kg
Intelligent Capability
Automatically records the timeout time

Maximum Operating Altitude Stability

<2000m Instrument life could last 5 years

Product Specification

Time Setting 3-30 mins

Temperature Setting 20°-40°C

Humidity ≤95%

Atmosphere Pressure 86.0-106.0KPa

Operating Altitude ＜2000m

Power Input DC12V, 5.0A

Dimension 220x160x72mm

Weight 1.4kg

Test Procedure

SET
SET

Channel1 Channel2 Channel3 Channel4 Channel5 Channel6

ON/OFF DC12V/5A

Channel1 Channel2 Channel3 Channel4 Channel5 Channel6 Channel1 Channel2 Channel3 Channel4 Channel5 Channel6

Turn on the power switch Press the SET button and Press the SET button and Insert the reagent card and
adjust the temperature setting adjust the time setting start to incubate

PAGE/04
Fluorescence Immunoassay Rapid Quantitative Test

Cardiac Marker
cTnI Myo
Troponin I (cTnI) can diagnose myocardial infarction and necrosis Assessed to diagnose acute myocardial infarction and help appropri-
at an early stage by accessing cTnI level in the blood. It helps ate treatment. Increased levels of Myo indicate cardiac muscle injury
prevent the progression of disease evolving into more severe or death which occurs in about 3 hours.
cases.

CK-MB D-Dimer
Assessed to diagnose myocardial infarction in 12-48 hours, the It measures the D-Dimer level in the blood to help assess the thrombot-
appearance of elevated CK-MB levels in serum is highly specific ic state, deep vein thrombosis, diffuse or disseminated intravascular
and sensitive to myocardial cell wall injury. coagulation, various embolisms including PE and strokes.

BNP NT-proBNP
Level of BNP in the blood can help assess the severity of heart An exclusion test for heart failure diagnosis that utilizes the level
diseases, including congestive heart failure. of NTproBNP in the blood to assess the cardiac event and its
severity.

cTnI/Myo/CK-MB/D-Dimer /NT-proBNP (5 in 1) hFABP

A diagnosis of coronary heart disease, angina pectoris, acute coronary Heart-type fatty acid binding protein appearing in the blood within
syndrome, thrombosis, myocardial injury, chest pain, chest tightness, a few hours of acute coronary syndrome (ACS) is also a reliable
and difficulty breathing for patients with heart failure. marker of myocardial necrosis.

HCY LP-PLA2
Test outcomes help to interpret the risk of cardiovascular and Test results help to understand the risks of developing coronary
cerebrovascular disease, stroke and even neurological diseases heart disease (CHD) or determine the risk of having an ischemic
such as Alzheimer's disease and Parkinson's disease. stroke.

s100-β
s100-β Quantitative Test is used as an aid detection of neuro-
logical injury. However，some recent studies clearly show the
relation between patient age and the release of s100-β up to 24
hours after cardiac surgery.
cTnI/Myo/CK-MB (3 in 1)
The combo test plays an important role in the diagnosis of acute
myocardial infarction (AMI) and acute coronary syndrome (ACS) .
It's also a more sensitive and earlier indicator of myocardial injury,
ischemic chest pain.

hscTnI
hs-cTnl can help explore small myocardial injuries that are easily
overlooked, facilitate earlier diagnosis of AMI, and more effectively
screen high-risk cardiovascular patients, thus optimizing clinical
treatment decisions and prognosis evaluation.

Test Item Qualification Specimen Sampling Reaction Time Detection Range

cTnI CE/NMPA Whole Blood/Plasma Whole Blood：

80μL/Plasma：
50μL 15min 0.05-50ng/mL

Myo CE/NMPA Serum/Plasma Serum：

10μL/Plasma：
10μL 15min 2.5-400ng/mL

CK-MB CE/NMPA Serum/Plasma Serum：

40μL/Plasma：
40μL 15min 1-80ng/mL

cTnI/Myo/CK-MB (3 in 1) CE/NMPA Whole Blood/Plasma Whole Blood：

80μL/Plasma：
50μL 15min Refer to individual item

D-Dimer CE/NMPA Whole Blood/Plasma Whole Blood：

80μL/Plasma：
50μL 3min 0.1-10mg/L

NT-proBNP CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

80μL/Serum：
50μL/Plasma：
50μL 15min 15-35000pg/mL

CTNI/MYO/CK-MB/D-DIMER /
CE/NMPA Whole Blood Whole Blood：
100μL 15min Refer to individual item
NT-PROBNP (5 IN 1)

hFABP CE/NMPA Serum/Plasma Serum：

10uL/Plasma：
10μL 15min 2-120ng/mL

BNP CE/NMPA Whole Blood/Plasma Whole Blood：

80μL/Plasma：
50μL 10min 10-5000pg/mL

LP-PLA2 CE/NMPA Whole Blood/Plasma Whole Blood：

30μL/Plasma：
20μL 10min 5-800ng/mL

HCY CE/NMPA Plasma Plasma：

40μL 15min 2-50umol/L

s100-β CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

60μL /Serum：
40μL/Plasma：
40μL 10min 0.05~10.0ug/L

hscTnI CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

60μL /Serum：
40μL/Plasma：
40μL 15min 20-40000pg/mL

PAGE/05
 Tumor Marker

AFP CEA/AFP(2 in 1)
It's used to test in pregnant women through the analysis of maternal The combo test helps the diagonosis of acute hepatitis and
blood or amniotic fluid as a screening test for certain developmental cirrhosis, primary liver cancer and congenital diseases such as
abnormalities, like aneuploidy. Also, serum AFP level is elevated in down syndrome.
people with certain tumors.

CEA fPSA
A high level of CEA in adults can be a sign of certain types of cancers in The free-PSA test measures the percentage of unbound PSA，
organs like the colon and rectum, prostate, ovary, lung, thyroid, or liver. prostate cancer, prostatitis, benign prostatic hyperplasia (BPH).

tPSA
A diagnosis of breast cancer and it helps in the early detection of
prostate diseases such as enlarged prostate and prostatitis and prostate
cancer by quantifying prostate specific antigen in male blood, as well as
observation of treatment effects and monitoring of recurrence.

Test Item Qualification Specimen Sampling Reaction Time Detection Range

AFP CE/NMPA Serum/Plasma Serum：

20μL/Plasma：
20μL 10min 3-2000ng/mL

CEA CE/NMPA Serum/Plasma Serum：

20μL/Plasma：
20μL 10min 0.5-500ng/mL

CEA/AFP(2 in 1) CE Serum/Plasma Serum：

20μL/Plasma：
20μL 10min Refer to individual item

tPSA CE Serum Serum：

20μL 15min 0.5-200ng/mL

fPSA CE Serum Serum：

20μL 15min 0.2-30ng/mL

Inflammatory Marker

CRP
A test measures the level of c-reactive protein (CRP) in the blood. Which
will be sent into the bloodstream in response to inflammation. Inflam-
mation is body's way of protecting the tissues if individuals been
injured or have an infection.
PCT
Procalcitonin determines severity of a sepsis and bacterial
infections. It can monitor effectiveness of Antibiotics therapy.
Provides data if the infection is caused by a bacteria.

SAA
SAA can be used for viral infections, systemic lupus erythemato-
sus and localized inflammation or tissue injuries also acute
kidney allograft rejection, after liver transplantation, simulta-
neous pancreas, kidney transplantation and bone marrow
transplantation.
CRP/SAA (2 in 1)
2 in 1 is response to inflammation. Inflammation is body's way
of protecting the tissues if individuals been injured or have an
infection. Including tissue injuries and acute kidney allograft
rejection, after liver transplantation, simulta neouspancreas.

IL-6
The IL-6 level is elevated with infection, sepsis, and septicemia. IL-6
is also elevated in numerous chronic inflammatory disorders,
including rheumatoid arthritis (RA), systemic lupus erythematosus
(SLE), ankylosing spondylitis (AS), and inflammatory bowel
disease (IBD).

Test Item Qualification Specimen Sampling Reaction Time Detection Range

CRP CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

5μL/Serum：
3μL/Plasma：
3μL 3min 0.5-200mg/L

PCT CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

80μL/Serum：
50μL/Plasma：
50μL 15min 0.1-100ng/mL

SAA CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

5μL/Serum：
3μL/Plasma：
3μL 3min 1-200mg/L

CRP/SAA(2 in 1) CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

5μL/Serum：
3μL/Plasma：
3μL 3min Refer to individual item

IL-6 CE/NMPA Serum Serum：

50μL 15min 5-1000pg/mL

PAGE/06
 Hormone Marker

β-HCG
This test helps to detect exact age of the fetus, possible miscar-
riages and abnormal pregnancy such as ectopic and molar
pregnancy during the 1st and 2nd Trimester. It is also very
important indicator in Down Syndrome detection during
pregnancy.
FSH/LH/PRL (3 in 1)
Combo test detects function of reproductive organs issues, infertility in
both male and female, Low sperm count, ED in men also irregular
menstrula cycle in women. Loss of sex drive indications also early or
delayed puberty in children.

FSH PROG
Test can indicate the function of reprooductive organs issues. Measures the level of progesterone in the blood. Result may
Infertility in both male and female, irrigular menstrual cycle in help provide answers to causes of infertility, risk of miscar-
women. Provides data on low sperm count and ED in men. riage, ovulation, and ectopic pregnancy.

PRL LH
This test helps to find lactation failure in women after childbirth. Test can indicate the function of reprooductive organs issues. Infertility
Tumor pituitary gland as well as disorders of the pituitary gland. as well low sex drive issues in both male and female, irrigular menstrual
Hypogonadism or gonadal failure in men. cycle in women. Early or delayed puberty in children.

TES(Testosterone)
Key role in the development of male reproductive organs and
secondary sexual traits. Test provides clues on the health of
related tissues and organs, related to infertility, tumors in
testicles, and even irregular periods in females.
E2
This test predicts the reason for early or late puberty in girls，find out
the reason for late puberty in boys, diagnose menstrual problems,
monitor pregnancy, abnormal pregnancy. It also assists the diagnosis
of twin or multiple pregnancies and pregnant women with diabetes.

AMH
AMH levels have become a useful fertility assessment tool that
helps guide women’s fertility treatment and family planning
decisions. Including the onset of menopause, amenorrhea,
polycystic ovary syndrome and ovarian hyperstimulation to
achieve pregnancy in IVF.

Test Item Qualification Specimen Sampling Reaction Time Detection Range

β-HCG CE/NMPA Serum/Plasma Serum：

20μL/Plasma：
20μL 10min 5-200000mIU/mL

PROG CE/NMPA Serum Serum：

40μL 10min 0.3-80ng/mL

FSH CE/NMPA Serum Serum：

20μL 20min 0.3-200mIU/mL

LH CE/NMPA Serum Serum：

20μL 20min 1-200mIU/mL

PRL CE/NMPA Serum Serum：

20μL 20min 1-4000uIU/mL

FSH/LH/PRL(3 in 1) CE/NMPA Serum Serum：

20μL 20min Refer to individual item

TES(Testosterone) CE/NMPA Serum Serum：

20μL 10min 0.2-20ng/mL

E2 CE/NMPA Serum Serum：

40μL(incubation10min) 10min 10-3000pg/mL

AMH CE Serum Serum：

50μL 10min 0.1-25ng/mL

PAGE/07
 Diabetes and Renal Injury Marker

HbA1c MAU
It helps the diabetic diagnosis, treatment, and prognosis by It assists in checking the extent of kidney damage and predicting
measuring the glycated hemoglobin concentration (%) in a small the progression to kidney failure, including receiving appropriate
amount of the blood over the past 3 months. treatment and confirming treatment effects.

Cys-C
When kidneys are not functioning properly, the cystatin level
increases. Tested for cys-c, it helps clinicians find GFR (Glomer-
ular Filtration Rate).

Test Item Qualification Specimen Sampling Reaction Time Detection Range

HbA1c CE/NMPA/NGSP Whole Blood Whole Blood：

5μL 5min 4-15%

MAU CE/NMPA Urine Urine：

10μL 10min 2-300mg/L

Cys-C CE/NMPA Whole Blood/Plasma Whole Blood：

15μL/Plasma：
10μL 5min 0.2-8mg/L

Thyroid marker

TSH
Test measures the amount of thyroid stimulating hormone,
diagnose thyroid dysfunction: Hyperthyroidism, Hypothyroidism,
indicates thryoid diseases during pregnancy and in newborns. The
results also show the treatment effectiveness.
TT4
It demonstrates how your body uses energy. Elevated T4 levels
may indicate hyperthyroidism and thyroid problems, such as
thyroiditis or toxic multinodular goiter.

TT3
It controls metabolism, body temperature, and heart rate. High TT3
level shows the risk for pregnancy complications, liver disease, and
may even reduce your sex drive.

Test Item Qualification Specimen Sampling Reaction Time Detection Range

TSH CE/NMPA Serum/Plasma Serum：

40μL/Plasma：
40μL 20min 0.4-100uIU/mL

TT4 CE/NMPA Serum/Plasma Serum：

40μL/Plasma：
40μL 15min 10-320nmol/L

TT3 CE/NMPA Serum Serum：

40μL 15min 0.5-10nmol/L

PAGE/08
 Gastrointestinal marker

PG I/PG II (2 in 1) PG I/PG II/G17

Human pepsinogen PGI and PGII are considered as the serological
biomarkers for screening atrophic gastritis (AG) and gastric cancer
(GC).
The serum level of G-17 can directly reflect the health status of the
gastric antrum mucosa and indirectly reflect the health status of
the gastric body. Studies have shown that abnormal G-17 levels
indicate a risk of precancerous lesions of the stomach, making it
an important indicator for screening gastric cancer.

Test Item Qualification Specimen Sampling Reaction Time Detection Range

PG I/PG II(2 in 1) CE/NMPA Serum Serum：

10μL 15min PG I：
1-200ng/mL PG II：
0.5-100ng/mL

PG I/PG II/G17 CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

60μL /Serum：
40μL 15min PG I：
1-200ng/mL PG II：
1-100ng/mL
Plasma：
40μL G17：
1-50pmoI/L

Others

Ferritin
Low ferritin level may also indicate hypothyroidism, vitamin C
deficiency or celiac disease. Ferritin Test provides a more sensitive,
specific and reliable measurement for determining iron deficiency
at an early stage.
25（OH）-D
Monitoring of vitamin D shows bone disease, bone weakness, or
osteoporosis. Vitamin D levels also helps the diagnosis for people
with chronic illnesses such as asthma, psoriasis, and certain
autoimmune diseases.

Total IgE
Test will assist better treatment of IgE-mediated allergic and autoim-
mune disorders.

Test Item Qualification Specimen Sampling Reaction Time Detection Range

Ferri tin CE/NMPA Serum Serum：

10μL 15min 1-1000ng/mL

25（OH）-D CE/NMPA Plasma Plasma：

20μL（incubation 10 min） 10min 5.0-120.0ng/mL

Total IgE CE Whole Blood/Serum/Plasma Whole Blood:30μL/Serum:20μL/Plasma:20μL 12min 1-1000IU/mL

PAGE/09
Test Item Qualification Specimen Sampling Reaction Time Detection Range

Cardiac Marker
cTnI CE/NMPA Whole Blood/Plasma Whole Blood：
80μL/Plasma：
50μL 15min 0.05-50ng/mL

Myo CE/NMPA Serum/Plasma Serum：

10μL/Plasma：
10μL 15min 2.5-400ng/mL

CK-MB CE/NMPA Serum/Plasma Serum：

40μL/Plasma：
40μL 15min 1-80ng/mL

cTnI/Myo/CK-MB (3 in 1) CE/NMPA Whole Blood/Plasma Whole Blood：

80μL/Plasma：
50μL 15min Refer to individual item

D-Dimer CE/NMPA Whole Blood/Plasma Whole Blood：

80μL/Plasma：
50μL 3min 0.1-10mg/L

NT-proBNP CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

80μL/Serum：
50μL/Plasma：
50μL 15min 15-35000pg/mL

CTNI/MYO/CK-MB/D-DIMER /
CE/NMPA Whole Blood Whole Blood：
100μL 15min Refer to individual item
NT-proBNP (5 IN 1)

hFABP CE/NMPA Serum/Plasma Serum：

10μL/Plasma：
10μL 15min 2-120ng/mL

BNP CE/NMPA Whole Blood/Plasma Whole Blood：

80μL/Plasma：
50μL 10min 10-5000pg/mL

LP-PLA2 CE/NMPA Whole Blood/Plasma Whole Blood：

30μL/Plasma：
20μL 10min 5-800ng/mL

HCY CE/NMPA Plasma Plasma：

40μL 15min 2-50umol/L

s100-β CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

60μL /Serum：
40μL/Plasma：
40μL 10 min 0.05~10.0ug/L

hscTnI CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

60μL /Serum：
40μL/Plasma：
40μL 15min 20-40000pg/mL

Tumor Marker
AFP CE/NMPA Serum/Plasma Serum：
20μL/Plasma：
20μL 10min 3-2000ng/mL

CEA CE/NMPA Serum/Plasma Serum：

20μL/Plasma：
20μL 10min 0.5-500ng/mL

CEA/AFP(2 in 1) CE Serum/Plasma Serum：

20μL/Plasma：
20μL 10min Refer to individual item

tPSA CE Serum Serum：

20μL 15min 0.5-200ng/mL

fPSA CE Serum Serum：

20μL 15min 0.2-30ng/mL

Inflammatory Marker
CRP CE/NMPA Whole Blood/Serum/Plasma Whole Blood：
5μL/Serum：
3μL/Plasma：
3μL 3min 0.5-200mg/L

PCT CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

80μL/Serum：
50μL/Plasma：
50μL 15min 0.1-100ng/mL

SAA CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

5μL/Serum：
3μL/Plasma：
3μL 3min 1-200mg/L

CRP/SAA(2 in 1) CE/NMPA Whole Blood/Serum/Plasma Whole Blood：

5μL/Serum：
3μL/Plasma：
3μL 3min Refer to individual item

IL-6 CE/NMPA Serum Serum：

50μL 15min 5-1000pg/mL

Hormone Marker
β-HCG CE/NMPA Serum/Plasma Serum：
20μL/Plasma：
20μL 10min 5-200000mIU/mL

PROG CE/NMPA Serum Serum：

40μL 10min 0.3-80ng/mL

FSH CE/NMPA Serum Serum：

20μL 20min 0.3-200mIU/mL

LH CE/NMPA Serum Serum：

20μL 20min 1-200mIU/mL

PRL CE/NMPA Serum Serum：

20μL 20min 1-4000uIU/mL

FSH/LH/PRL(3 in 1) CE/NMPA Serum Serum：

20μL 20min Refer to individual item

TES(Testosterone) CE/NMPA Serum Serum：

20μL 10min 0.2-20ng/mL

E2 CE/NMPA Serum Serum：

40μL(incubation10min) 10min 10-3000pg/mL

AMH CE Serum Serum：

50μL 10min 0.1-25ng/mL

Diabetes and Renal Injury Marker

HbA1c CE/NMPA/NGSP Whole Blood Whole Blood：
5μL 5min 4-15%

MAU CE/NMPA Urine Urine：

10μL 10min 2-300mg/L

Cys-C CE/NMPA Whole Blood/Plasma Whole Blood：

15μL/Plasma：
10μL 5min 0.2-8mg/L

Thyroid Marker
TSH CE/NMPA Serum/Plasma Serum：
40μL/Plasma：
40μL 20min 0.4-100uIU/mL

TT4 CE/NMPA Serum/Plasma Serum：

40μL/Plasma：
40μL 15min 10-320nmol/L

TT3 CE/NMPA Serum Serum：

40μL 15min 0.5-10nmol/L

Gastrointestinal Marker
PG I：1-200ng/mL
2 in 1（PG I/PG II) CE/NMPA Serum Serum：
10μL 15min
PG II：0.5-100ng/mL
PG I：1-200ng/mL
PG I/PG II/G17 CE/NMPA Whole Blood/Serum/Plasma Whole Blood：
60μL /Serum：
40μL /Plasma：
40μL 15min PG II：1-100ng/mL
G17： 1-50pmoI/L

Others
Ferri tin CE/NMPA Serum Serum：
10μL 15min 1-1000ng/mL

25（OH）-D CE/NMPA Plasma Plasma：

20μL（incubation 10 min） 10min 5.0-120.0ng/mL

Total IgE CE Whole Blood/Serum/Plasma Whole Blood:30μL/Serum:20μL/Plasma:20μL 12min 1-1000IU/mL

All the parameters above are subject to the instructions.

 Rapid, Beyond Imagination

Xiamen Biotime Biotechnology Co., Ltd.

Add: 2F/3F/4F/5F, No.188, Pingcheng South Road, Haicang Street, Haicang District, Xiamen City, Fujian Province, 361026, P. R. China.
Tel: +86-592-688-3156 Fax: +86-592-6882362 E-mail: baotai@biotime.cn Web: www.xiamenbiotime.com